Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IVAX Insider Trading -- Ignore unavailable to you. Want to Upgrade?

To: Ken Adams who wrote (576)	3/18/1998 11:52:00 AM
From: Rainier	Read Replies (1) \| Respond to of 756

Hi Ken, It's never wrong to take a profit -- in fact, it shows discipline. I'm going to hold my long position for a while longer, mainly because I think the company is still undervalued and due for a turnaround or takeover. I'm not a technician, but I noticed the big blocks (20,000 to 100,000 shares) were crossing on the uptick (suggesting accumulation) the last several days. As has been noted, the volume hasn't been too impressive; just one day of 600,000+, I believe. I'm wondering if there may be some truth in the BASF rumor mentioned in MikeC2's prior post. As I recall, BASF holds some 6 million shares as of the last annual report; an increase of 8 million would make them the second largest shareholder after Frost who has 16 million or so. Will look through the rights offering terms IVX sent out a month or so ago and post details when I have more time. Would be interested in knowing what you, as a technician, look at to determine entry and exit points. Lisa

To: Ken Adams who wrote (576)	3/19/1998 12:26:00 AM
From: Charles Holewinski	Read Replies (1) \| Respond to of 756

Thanks for the info Ken. BTW did you know that IVAX has some Convert Bonds which are paying a nice return and are selling below par. They are much safer than the stock and you get a nice payout. I have the 6.5% of 11/15/01 which are currently selling for about 86. That is a 7.55% current yield with the yield to maturity well over 8%. I don't think there is much risk in these bonds since while the company is not making much money, it has enough licenses from the FDA to be of some value in the long run.